One of the big reasons to like Pfizer (NYSE: PFE) today is its huge 7.1% dividend yield. Pfizer competitor Merck (NYSE: MRK) ...

Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an update on ClinicalTrials.gov, the company stated the study (NCT05626322) was ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...

Pfizer CEO Albert Bourla said during an investor call Tuesday the Food and Drug Administration could authorize the company’s new Covid-19 booster shot by the end of the month—moving closer to ...

This was the stock's third consecutive day of losses.

Pfizer also may have to figure out whether to cut production of another product to squeeze in more manufacturing at the new site.

Pfizer CEO Albert Bourla heralded the site launch in a post on LinkedIn, noting that PfizerForAll seeks to aid Americans “overwhelmed by the abundance of online health information.” Going forward, the ...